Arbutus Biopharma Corp (ABUS)
2.73
+0.01
(+0.37%)
USD |
NASDAQ |
Apr 26, 16:00
2.72
-0.01
(-0.37%)
After-Hours: 20:00
Arbutus Biopharma Profit Margin (Quarterly): -900.3% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -900.3% |
| September 30, 2023 | -431.6% |
| June 30, 2023 | -367.5% |
| March 31, 2023 | -244.3% |
| December 31, 2022 | -351.2% |
| September 30, 2022 | -295.1% |
| June 30, 2022 | -99.66% |
| March 31, 2022 | -125.3% |
| December 31, 2021 | -665.0% |
| September 30, 2021 | -573.6% |
| June 30, 2021 | -832.4% |
| March 31, 2021 | -775.2% |
| December 31, 2020 | -714.2% |
| September 30, 2020 | -1.23K% |
| June 30, 2020 | -930.4% |
| March 31, 2020 | -929.6% |
| December 31, 2019 | -1.52K% |
| September 30, 2019 | -2.70K% |
| June 30, 2019 | -3.57K% |
| March 31, 2019 | -3.42K% |
| December 31, 2018 | -1.09K% |
| September 30, 2018 | -1.54K% |
| June 30, 2018 | |
| March 31, 2018 | -1.21K% |
| December 31, 2017 | -1.42K% |
| Date | Value |
|---|---|
| September 30, 2017 | -168.3% |
| June 30, 2017 | -1.76K% |
| March 31, 2017 | -7.93K% |
| December 31, 2016 | |
| September 30, 2016 | -2.53K% |
| June 30, 2016 | -42.07K% |
| March 31, 2016 | -2.63K% |
| December 31, 2015 | -61.87% |
| September 30, 2015 | -713.0% |
| June 30, 2015 | -432.7% |
| March 31, 2015 | -256.1% |
| December 31, 2014 | -141.8% |
| September 30, 2014 | -197.2% |
| June 30, 2014 | -335.8% |
| March 31, 2014 | -406.0% |
| December 31, 2013 | -34.52% |
| September 30, 2013 | -199.3% |
| June 30, 2013 | -106.0% |
| March 31, 2013 | -119.4% |
| December 31, 2012 | |
| September 30, 2012 | -112.7% |
| June 30, 2012 | -53.13% |
| March 31, 2012 | -88.66% |
| December 31, 2011 | -52.16% |
| September 30, 2011 | -35.32% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.57K%
Minimum
Jun 2019
-99.66%
Maximum
Jun 2022
-908.2%
Average
-714.2%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | 7.71% |
| Pacira BioSciences Inc | 13.72% |
| Chimerix Inc | -454.0K% |
| Karyopharm Therapeutics Inc | -124.0% |
| Corvus Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.84% |
| Return on Assets | -42.04% |
| Return on Invested Capital | -56.84% |
| Operating Margin (Quarterly) | -956.6% |
| Return on Net Operating Assets | -837.6% |